These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12567708)

  • 1. [Toxic effects of levamisole].
    Wen LY; Song CC
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(3):186-7. PubMed ID: 12567708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Side effects in the clinical use of levamisole].
    Sachanbiński A; Mielczarek S; Przywara S
    Wiad Lek; 1985 Feb; 38(3):207-9. PubMed ID: 3159158
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complications of the treatment with non-steroidal anti-inflammatory drugs].
    Gritsiuk AI; Angelutsa PA; Viktorov AP
    Sov Med; 1990; (10):39-43. PubMed ID: 2149889
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adverse effects of chemical mediator release inhibitors].
    Onoda M; Inokuma S; Ikezawa Z
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():259-66. PubMed ID: 18074547
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proposed model for evaluation of toxicity in antineoplastic chemo-hormonotherapy].
    Pannuti F; Martoni A; Piana E; Palenzona D
    Minerva Med; 1978 Nov; 69(55):3761-72. PubMed ID: 153486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adverse effects of antibiotics].
    Ono Y
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():224-31. PubMed ID: 18074543
    [No Abstract]   [Full Text] [Related]  

  • 7. [Side effects of gold salts].
    Renier JC; Boasson M
    Therapie; 1976; 31(3):365-76. PubMed ID: 136766
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fixed pigmented erythema caused by levamisole administration].
    Clavère P; Bonnafoux-Clavère A; Delrous JL; Bonnetblanc JM; Olivier JP
    Ann Dermatol Venereol; 1994; 121(3):238-9. PubMed ID: 7832552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complications of non-steroidal anti-inflammatory agents].
    Sallière D
    Rev Prat; 1987 Oct; 37(41):2507-13. PubMed ID: 2961044
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse effects resulting from nitrofurantoin administration.
    Delaney RA; Miller DA; Gerbino PP
    Am J Pharm Sci Support Public Health; 1977; 149(1):26-8. PubMed ID: 141888
    [No Abstract]   [Full Text] [Related]  

  • 11. Late toxic effects of cytotoxic drugs.
    Fortuny IE; Theologides A
    Minn Med; 1974 Jan; 57(1):19-21 passim. PubMed ID: 4592758
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dermatopathy associated with levamisole-induced reversible posterior leukoencephalopathy].
    Boente Mdel C; Bibas Bonet H; Primc NB
    Arch Argent Pediatr; 2008 Feb; 106(1):42-6. PubMed ID: 18636134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side-effects of non-steroidal anti-inflammatory drugs.
    Brooks PM
    Med J Aust; 1988 Mar; 148(5):248-51. PubMed ID: 2963948
    [No Abstract]   [Full Text] [Related]  

  • 14. [On iatrogenic damage caused by chemoantibiotic therapy of chronic bronchopneumopathies].
    Serra C
    Minerva Med; 1971 Feb; 62(16):770-5. PubMed ID: 4251442
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immediate and late harmful manifestations and results of parenteral and local corticotherapy in chronic rheumatic patients].
    Marin D
    Minerva Med; 1971 Feb; 62(16):758-63. PubMed ID: 4251441
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse effects of corticosteroids: II. Systemic.
    Davis GF
    Clin Dermatol; 1986; 4(1):161-9. PubMed ID: 2978681
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug side effects in antineoplastic and immunosuppressive cytostatic therapy].
    Hambsch K; Fischer H
    Z Gesamte Inn Med; 1984 Jan; 39(1):7-14. PubMed ID: 6711064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical safety of azithromycin].
    Higa F; Saito A
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():125-35. PubMed ID: 12572096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing chemotherapy-associated toxicity in elderly cancer patients.
    Zagonel V; Fratino L; Sacco C; Babare R; Spazzapan S; Gattei V; Improta S; Pinto A
    Cancer Treat Rev; 1996 May; 22(3):223-44. PubMed ID: 8841391
    [No Abstract]   [Full Text] [Related]  

  • 20. [Monoclonal antibodies and chemotherapy: planning and management of symptoms].
    Berardini R
    Suppl Tumori; 2004; 3(4):S130-2. PubMed ID: 15206239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.